Abstract
1 The effect of the new, short-acting benzodiazepine, midazolam as well as that of triazolam and flunitrazepam on the sleep of rabbits was recorded for 6 h.
2 Midazolam at 1 mg kg-1 i.v. augmented both rapid eye movement sleep (REMS) and non-REM sleep (NREMS) only in the first half of the observation period. At 10 mg kg-1 i.v., NREMS was further increased in the first and, to a lesser degree, in the second 3-h period, while REMS was suppressed. Both doses were less effective orally than intravenously.
3 Qualitatively, the effect of triazolam 0.01 and 0.1 mg kg-1 i.v. was very similar to that of the corresponding low and high intravenous doses of midazolam, except that the high dose of triazolam had a prolonged effect on total sleep time. Like midazolam, triazolam was substantially less effective orally than intravenously.
4 Flunitrazepam at 0.1 and 1 mg kg-1 i.v. produced almost the same effects as midazolam and triazolam at the respective low and high intravenous doses, but had a longer duration of action. In contrast to midazolam and triazolam, flunitrazepam was almost as active orally as intravenously.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boxenbaum H. G., Posmanter H. N., Macasieb T., Geitner K. A., Weinfeld R. E., Moore J. D., Darragh A., O'Kelly D. A., Weissman L., Kaplan S. A. Pharmacokinetics of flunitrazepam following single- and multiple-dose oral administration to healthy human subjects. J Pharmacokinet Biopharm. 1978 Aug;6(4):283–293. doi: 10.1007/BF01060092. [DOI] [PubMed] [Google Scholar]
- Cano J. P., Guintrand J., Aubert C., Viala A. Determination of flunitrazepam, desmethylflunitrazepam and clonazepam in plasma by gas liquid chromatography with an internal standard. Arzneimittelforschung. 1977 Feb;27(2):338–342. [PubMed] [Google Scholar]
- Crevoisier C., Ziegler W. H., Eckert M., Heizmann P. Relationship between plasma concentration and effect of midazolam after oral and intravenous administration. Br J Clin Pharmacol. 1983;16 (Suppl 1):51S–61S. doi: 10.1111/j.1365-2125.1983.tb02271.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eberts F. S., Jr Disposition of triazolam, 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a]benzodiazepine, in the dog. Drug Metab Dispos. 1977 Nov-Dec;5(6):547–555. [PubMed] [Google Scholar]
- Eberts F. S., Jr, Philopoulos Y., Reineke L. M., Vliek R. W. Triazolam disposition. Clin Pharmacol Ther. 1981 Jan;29(1):81–93. doi: 10.1038/clpt.1981.14. [DOI] [PubMed] [Google Scholar]
- Gerecke M. Chemical structure and properties of midazolam compared with other benzodiazepines. Br J Clin Pharmacol. 1983;16 (Suppl 1):11S–16S. doi: 10.1111/j.1365-2125.1983.tb02266.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hoffmeister F. Elektroenzephalogramm und Verhalten von Kaninchen im physiologischen und medikamentösen Schlaf. 2. EEG des Kaminchens im medikamentösen Schlaf. Arzneimittelforschung. 1972 Feb;22(2):412–421. [PubMed] [Google Scholar]
- Kitagawa H., Esumi Y., Kurosawa S., Sekine S., Yokoshima T. Metabolism of 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo [4,3-alpha] [1,4] benzodiazepine, triazolam, a new central depressant. I. Absorption, distribution and excretion in rats, dogs and monkeys. Xenobiotica. 1979 Jul;9(7):415–428. doi: 10.3109/00498257909038746. [DOI] [PubMed] [Google Scholar]
- Pieri L. Preclinical pharmacology of midazolam. Br J Clin Pharmacol. 1983;16 (Suppl 1):17S–27S. doi: 10.1111/j.1365-2125.1983.tb02267.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pieri L., Schaffner R., Scherschlicht R., Polc P., Sepinwall J., Davidson A., Möhler H., Cumin R., Da Prada M., Burkard W. P. Pharmacology of midazolam. Arzneimittelforschung. 1981;31(12A):2180–2201. [PubMed] [Google Scholar]
- Vree T. B., Baars A. M., Booij L. H., Driessen J. J. Simultaneous determination and pharmacokinetics of midazolam and its hydroxymetabolites in plasma and urine of man and dog by means of high-performance liquid chromatography. Arzneimittelforschung. 1981;31(12A):2215–2219. [PubMed] [Google Scholar]
- Woo G. K., Williams T. H., Kolis S. J., Warinsky D., Sasso G. J., Schwartz M. A. Biotransformation of [14C]midazolam in the rat in vitro and in vivo. Xenobiotica. 1981 Jun;11(6):373–384. doi: 10.3109/00498258109045848. [DOI] [PubMed] [Google Scholar]